3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Lymphoma, Non-Hodgkin
16
Myelodysplastic Syndromes
15
Leukemia, Myeloid, Acute
15
Leukemia, Lymphocytic, Chronic, B-Cell
15
Hodgkin Disease
15
Lymphoma, Mantle-Cell
14
Multiple Myeloma
13
Waldenstrom Macroglobulinemia
12
Graft vs Host Disease
12
Lymphoma, Large B-Cell, Diffuse
11
Lymphoma
11
Leukemia
11
Lymphoma, Follicular
10
Lymphoma, B-Cell, Marginal Zone
10
Sarcoma
9
Myeloproliferative Disorders
9
Burkitt Lymphoma
9
Tuberous Sclerosis
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Primary Myelofibrosis
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Neoplasms
6
Lymphoma, Large-Cell, Immunoblastic
6
Leukemia, Myelomonocytic, Chronic
6
Congenital Abnormalities
6
Breast Neoplasms
6
Myelodysplastic-Myeloproliferative Diseases
5
Lymphoma, Large-Cell, Anaplastic
5
Lymphangioleiomyomatosis
5
Interventions
pembrolizumab
37
Paclitaxel
36
Carboplatin
31
Cyclophosphamide
22
Albumin-Bound Paclitaxel
20
atezolizumab
16
130-nm albumin-bound paclitaxel
16
Taxes
15
Doxorubicin
15
Cisplatin
13
Capecitabine
13
Nivolumab
10
Docetaxel
8
olaparib
7
Gemcitabine
6
Everolimus
6
talazoparib
5
durvalumab
5
Magnetic Resonance Spectroscopy
5
Biopsy
5
Bevacizumab
5
veliparib
4
spartalizumab
4
sacituzumab govitecan
4
pegfilgrastim
4
liposomal doxorubicin
4
eribulin
4
Specimen Handling
4
Immunoglobulin G
4
trilaciclib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Triple Negative Breast Neoplasms
×
Sirolimus
×
Clear all
No trials found.